HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jaime Masjuan Selected Research

Arterial Occlusive Diseases (Arterial Occlusive Disease)

2/2014Acute ischemic stroke in a 12-year-old successfully treated with mechanical thrombectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jaime Masjuan Research Topics

Disease

18Stroke (Strokes)
05/2024 - 09/2008
12Ischemic Stroke
05/2024 - 07/2011
8Multiple Sclerosis
08/2023 - 02/2003
8Atrial Fibrillation
01/2023 - 01/2012
7Hemorrhage
12/2022 - 01/2014
6Transient Ischemic Attack
01/2024 - 04/2012
5Embolic Stroke
01/2024 - 10/2012
4Brain Ischemia (Cerebral Ischemia)
12/2023 - 09/2021
4Cerebral Hemorrhage
01/2021 - 01/2012
3Ischemia
05/2023 - 09/2021
2Hematoma
04/2024 - 10/2011
2Infarction (Infarctions)
01/2024 - 06/2022
2COVID-19
01/2023 - 04/2021
2Inflammation (Inflammations)
10/2022 - 01/2022
2Thrombosis (Thrombus)
01/2022 - 12/2017
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
04/2021 - 01/2021
2Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2018 - 08/2017
2Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
07/2014 - 02/2008
1Brain Infarction
01/2024
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Conversion Disorder (Astasia Abasia)
01/2023
1Infections
12/2022
1Macrophage Activation Syndrome
10/2022
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022
1Chronic Progressive Multiple Sclerosis
01/2022
1Embolism (Embolus)
01/2022
1Heart Failure
01/2022
1Myocardial Infarction
01/2022
1Relapsing-Remitting Multiple Sclerosis
01/2021
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2020
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2020
1Multiple System Atrophy
11/2019
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2019
1Corticobasal Degeneration
11/2019
1Nervous System Diseases (Neurological Disorders)
07/2014
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
07/2014
1Neurologic Manifestations (Neurological Manifestations)
02/2014
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
02/2014
1Hematuria
01/2014
1Metrorrhagia (Spotting)
01/2014
1Dyslipidemias (Dyslipidemia)
01/2012
1Hypertension (High Blood Pressure)
01/2012
1Seizures (Absence Seizure)
09/2011
1Rupture
09/2011
1Neoplasms (Cancer)
01/2007

Drug/Important Bio-Agent (IBA)

8AnticoagulantsIBA
01/2024 - 01/2012
5RivaroxabanIBA
01/2023 - 01/2019
4Vitamin KFDA Link
12/2022 - 01/2017
4DabigatranFDA Link
01/2019 - 07/2011
3Factor XIa (Coagulation Factor XIa)IBA
05/2024 - 01/2022
3Eukaryotic Initiation Factor-4EIBA
05/2023 - 09/2021
3Oligoclonal BandsIBA
01/2023 - 01/2005
3Biomarkers (Surrogate Marker)IBA
09/2021 - 11/2019
3Warfarin (Coumadin)FDA LinkGeneric
08/2017 - 10/2012
3AntibodiesIBA
07/2014 - 01/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
04/2012 - 09/2008
2AntioxidantsIBA
12/2023 - 06/2022
2Proteins (Proteins, Gene)FDA Link
05/2023 - 09/2021
2COVID-19 VaccinesIBA
04/2023 - 01/2023
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2021
2Immunoglobulin G (IgG)IBA
12/2022 - 04/2005
2Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2012
2Peptide Initiation Factors (Initiation Factor)IBA
02/2022 - 09/2021
2Immunoglobulin M (IgM)IBA
01/2021 - 02/2003
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 01/2019
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
02/2008 - 01/2007
1VaccinesIBA
08/2023
1collapsin response mediator protein-2IBA
05/2023
1Protein Isoforms (Isoforms)IBA
05/2023
1Rituximab (Mabthera)FDA Link
12/2022
1Interleukin-6 (Interleukin 6)IBA
10/2022
1Neuroprotective AgentsIBA
06/2022
1nitronesIBA
06/2022
1Oxygen (Dioxygen)IBA
06/2022
1omega-Chloroacetophenone (Mace)IBA
01/2022
1ocrelizumabIBA
01/2022
1SteroidsIBA
04/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2021
1Alemtuzumab (Campath)FDA Link
01/2021
1PF-05230907IBA
01/2021
1LipidsIBA
01/2020
1Ramipril (Altace)FDA LinkGeneric
01/2020
1Atorvastatin (Lipitor)FDA Link
01/2020
1edoxabanIBA
08/2017
1apixabanIBA
10/2012
1Cytidine Diphosphate Choline (Citicoline)IBA
07/2012
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2012
1Cocaine (Cocaine HCl)IBA
09/2011
1A-factor (Streptomyces)IBA
08/2011

Therapy/Procedure

8Therapeutics
05/2024 - 01/2012
4Secondary Prevention
01/2022 - 10/2012
3Thrombectomy
09/2018 - 02/2014
2Craniotomy
04/2024 - 10/2011
2Artificial Respiration (Mechanical Ventilation)
04/2021 - 01/2021
2Thrombolytic Therapy
10/2012 - 04/2012
2Treatment Delay
01/2012 - 01/2012
1Intravenous Administration
06/2022
1Aftercare (After-Treatment)
09/2018
1Patient Care
01/2018
1Decompressive Craniectomy
10/2011